Inflammatory cell death pathway
PANoptosis is a prominent unique, innate immune, inflammatory, and lytic
cell death pathway initiated by innate immune sensors and driven by
caspases and RIPKs through multiprotein PANoptosome complexes.
[1]
[2] The assembly of the PANoptosome cell death complex occurs in response to germline-encoded
pattern-recognition receptors (PRRs) sensing pathogens, including bacterial, viral, and fungal infections, as well as
pathogen-associated molecular patterns ,
damage-associated molecular patterns , and
cytokines that are released during infections, inflammatory conditions, and
cancer .
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[1] Several PANoptosome complexes, such as the
ZBP1 -,
AIM2 -,
RIPK1 -,
NLRC5 - and
NLRP12 -PANoptosomes, have been characterized so far.
[1]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
Emerging genetic, molecular, and biochemical studies have identified extensive crosstalk among the molecular components across various cell death pathways in response to a variety of
pathogens and innate immune triggers.
[3]
[4] Historically, inflammatory
caspase -mediated
pyroptosis and RIPK-driven
necroptosis were described as two major inflammatory cell death pathways. While the PANoptosis pathway has some molecular components in common with
pyroptosis and
necroptosis , as well as with the non-lytic
apoptosis pathway, these mechanisms are separate processes that are associated with distinct triggers, protein complexes, and execution pathways.
[2]
Inflammasome -dependent pyroptosis involves inflammatory caspases, including
caspase-1 and
caspase-11 in mice, and caspases-1,
- 4 , and -
5 in humans, and is executed by
gasdermin D .
[24]
[25]
[26]
[27]
[28]
[29]
[30] In contrast, necroptosis occurs via RIPK1/3-mediated MLKL activation, which is downstream of
caspase-8 inhibition.
[31]
[32]
[33]
[34] On the other hand, PANoptosis is [TDK1] driven by caspases and RIPKs and is executed by gasdermins, MLKL, and potentially other yet to be identified molecules cleaved by caspases.
[35]
[36]
[37]
[38]
[39]
[40]
[19]
[21] Moreover, caspase-8 is essential for cell death in PANoptosis
[41]
[42] but needs to be inactivated or inhibited to induce necroptosis.
[43]
[44]
PANoptosis has now been identified in a variety of infections, including viral (
influenza A virus ,
herpes simplex virus 1 (HSV1) ,
coronavirus ), bacterial (
Yersinia pseudotuberculosis ,
Francisella novicida ), and fungal (
Candida albicans ,
Aspergillus fumigatus ). PANoptosis has also been implicated in inflammatory diseases, neurological diseases, and cancer.
[45]
[46]
[47]
[48]
[49]
[50]
[51]
[52]
[53]
[54] Activation of PANoptosis can clear infected cells for host defense, and it has shown preclinical promise as an anti-cancer strategy. For example, PANoptosis is important for host defense during influenza infection through the ZBP1-PANoptosome and during
Francisella and HSV1 infections through the AIM2-PANoptosome.
[5]
[7]
[17]
[19] Additionally, treatment of cancer cells with the PANoptosis-inducing agents TNF and IFN-γ
[55]
[6] can reduce tumor size in preclinical models.
[56] The combination of the nuclear export inhibitor
selinexor and
IFN can also cause PANoptosis and regress tumors in preclinical models.
[3]
[57] However, excess activation of PANoptosis can be associated with
inflammation , inflammatory disease, and
cytokine storm syndromes.
[6]
[11]
[58]
[21]
[1] Treatments that block TNF and IFN-γ to prevent PANoptosis have provided therapeutic benefit in preclinical models of cytokine storm syndromes, including cytokine shock,
SARS-CoV-2 infection,
sepsis , and
hemophagocytic lymphohistiocytosis , suggesting the therapeutic potential of modulating this pathway.
[6]
[59] Further studies with beta-coronaviruses have shown that IFN can induce
ZBP1 -mediated PANoptosis during SARS-CoV-2 infection, thereby limiting the efficacy of IFN treatment during infection and resulting in morbidity and mortality. This suggests that inhibiting ZBP1 may improve the therapeutic efficacy of IFN therapy during SARS-CoV-2 infection and possibly other inflammatory conditions where IFN-mediated cell death and pathology occur.
[60]
[61] More recent evidence suggests that
NLRP12 -mediated PANoptosis is activated by
heme , which can be released by red blood cell lysis during infection or inflammatory disease, in combination with specific components of infection or cellular damage. Deletion of NLRP12 protects against pathology in animal models of hemolytic disease, suggesting this could also act as a therapeutic target. Similarly, the NLRC5-PANoptosome, which also contains NLRP12, was identified as a response to
NAD + depletion downstream of heme-containing triggers. Deletion of NLRC5 protects against not only hemolytic disease models, but also
colitis and
HLH models.
[22]
[23] Additionally, PANoptosis can also be induced by heat stress (HS), such as fever, during infection, and NINJ1 is a known key executioner in this context. Deletion of NINJ1 in a murine model of HS and infection reduces mortality; furthermore, deleting essential PANoptosis effectors upstream completely rescues the mice from mortality, thereby identifying NINJ1 and PANoptosis effectors as potential therapeutic targets.
[62]
The regulation of PANoptosis involves numerous PANoptosomes, which encompass multiple sensor molecules such as
NLRP3 , ZBP1, AIM2, and NLRP12, along with complex-forming molecules such as caspases and RIPKs. These components activate various downstream cell death executioners and play a role in disease. Therefore, modulating the components of this pathway has potential for therapy.
References
^
a
b
c
d
"St. Jude finds NLRP12 as a new drug target for infection, inflammation and hemolytic diseases" . www.stjude.org . Retrieved 2024-03-07 .
^
a
b Pandeya, Ankit; Kanneganti, Thirumala-Devi (January 2024).
"Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes" . Trends in Molecular Medicine . 30 (1): 74–88.
doi :
10.1016/j.molmed.2023.10.001 .
ISSN
1471-499X .
PMC 10842719.
PMID
37977994 .
^
a
b
c
"Promising preclinical cancer therapy harnesses a newly discovered cell death pathway" . www.stjude.org . Retrieved 2021-11-16 .
^
a
b
"ZBP1 links interferon treatment and dangerous inflammatory cell death during COVID-19" . www.stjude.org . Retrieved 2022-06-02 .
^
a
b
"The PANoptosome: a new frontier in innate immune responses" . www.stjude.org . Retrieved 2021-11-16 .
^
a
b
c
d
"In the lab, St. Jude scientists identify possible COVID-19 treatment" . www.stjude.org . Retrieved 2021-11-16 .
^
a
b
"Discovering the secrets of the enigmatic caspase-6" . www.stjude.org . Retrieved 2021-11-16 .
^
"Breaking the dogma: Key cell death regulator has more than one way to get the job done" . www.stjude.org . Retrieved 2021-11-16 .
^ Kuriakose, Teneema; Man, Si Ming; Malireddi, R.K. Subbarao; Karki, Rajendra; Kesavardhana, Sannula; Place, David E.; Neale, Geoffrey; Vogel, Peter; Kanneganti, Thirumala-Devi (2016-08-05).
"ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways" . Science Immunology . 1 (2): aag2045.
doi :
10.1126/sciimmunol.aag2045 .
ISSN
2470-9468 .
PMC
5131924 .
PMID
27917412 .
^ Karki, Rajendra; Sharma, Bhesh Raj; Lee, Ein; Banoth, Balaji; Malireddi, R.K. Subbarao; Samir, Parimal; Tuladhar, Shraddha; Mummareddy, Harisankeerth; Burton, Amanda R.; Vogel, Peter; Kanneganti, Thirumala-Devi (2020-06-18).
"Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer" . JCI Insight . 5 (12).
doi :
10.1172/jci.insight.136720 .
ISSN
2379-3708 .
PMC
7406299 .
PMID
32554929 .
^
a
b
"Diet affects mix of intestinal bacteria and the risk of inflammatory bone disease" . www.stjude.org . Retrieved 2020-09-11 .
^ Malireddi, R. K. Subbarao; Karki, Rajendra; Sundaram, Balamurugan; Kancharana, Balabhaskararao; Lee, SangJoon; Samir, Parimal; Kanneganti, Thirumala-Devi (2021-07-21).
"Inflammatory Cell Death, PANoptosis, Mediated by Cytokines in Diverse Cancer Lineages Inhibits Tumor Growth" . ImmunoHorizons . 5 (7): 568–580.
doi :
10.4049/immunohorizons.2100059 .
ISSN
2573-7732 .
PMC
8522052 .
PMID
34290111 .
^ Karki, Rajendra; Sharma, Bhesh Raj; Tuladhar, Shraddha; Williams, Evan Peter; Zalduondo, Lillian; Samir, Parimal; Zheng, Min; Sundaram, Balamurugan; Banoth, Balaji; Malireddi, R. K. Subbarao; Schreiner, Patrick (2021-01-07).
"Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes" . Cell . 184 (1): 149–168.e17.
doi :
10.1016/j.cell.2020.11.025 .
ISSN
1097-4172 .
PMC
7674074 .
PMID
33278357 .
^ Karki, Rajendra; Lee, SangJoon; Mall, Raghvendra; Pandian, Nagakannan; Wang, Yaqiu; Sharma, Bhesh Raj; Malireddi, Rk Subbarao; Yang, Dong; Trifkovic, Sanja; Steele, Jacob A.; Connelly, Jon P. (2022-05-19).
"ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection" . Science Immunology . 7 (74): eabo6294.
doi :
10.1126/sciimmunol.abo6294 .
ISSN
2470-9468 .
PMC
9161373 .
PMID
35587515 .
^ Wang, Yaqiu; Pandian, Nagakannan; Han, Joo-Hui; Sundaram, Balamurugan; Lee, SangJoon; Karki, Rajendra; Guy, Clifford S.; Kanneganti, Thirumala-Devi (2022-09-28).
"Single cell analysis of PANoptosome cell death complexes through an expansion microscopy method" . Cellular and Molecular Life Sciences . 79 (10): 531.
doi :
10.1007/s00018-022-04564-z .
ISSN
1420-9071 .
PMC
9545391 .
PMID
36169732 .
^ Sundaram, Balamurugan; Pandian, Nagakannan; Mall, Raghvendra; Wang, Yaqiu; Sarkar, Roman; Kim, Hee Jin; Malireddi, R.K. Subbarao; Karki, Rajendra; Janke, Laura J.; Vogel, Peter; Kanneganti, Thirumala-Devi (June 2023).
"NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs" . Cell . 186 (13): 2783–2801.e20.
doi :
10.1016/j.cell.2023.05.005 .
PMC
10330523 .
PMID
37267949 .
^
a
b Zheng, Min; Karki, Rajendra; Vogel, Peter; Kanneganti, Thirumala-Devi (2020-04-30).
"Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense" . Cell . 181 (3): 674–687.e13.
doi :
10.1016/j.cell.2020.03.040 .
ISSN
1097-4172 .
PMC
7425208 .
PMID
32298652 .
^ Christgen, Shelbi; Zheng, Min; Kesavardhana, Sannula; Karki, Rajendra; Malireddi, R. K. Subbarao; Banoth, Balaji; Place, David E.; Briard, Benoit; Sharma, Bhesh Raj; Tuladhar, Shraddha; Samir, Parimal; Burton, Amanda; Kanneganti, Thirumala-Devi (2020).
"Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)" . Frontiers in Cellular and Infection Microbiology . 10 : 237.
doi :
10.3389/fcimb.2020.00237 .
ISSN
2235-2988 .
PMC
7274033 .
PMID
32547960 .
^
a
b
c Lee, SangJoon; Karki, Rajendra; Wang, Yaqiu; Nguyen, Lam Nhat; Kalathur, Ravi C.; Kanneganti, Thirumala-Devi (September 2021).
"AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence" . Nature . 597 (7876): 415–419.
Bibcode :
2021Natur.597..415L .
doi :
10.1038/s41586-021-03875-8 .
ISSN
1476-4687 .
PMC
8603942 .
PMID
34471287 .
^ Malireddi, R. K. Subbarao; Kesavardhana, Sannula; Karki, Rajendra; Kancharana, Balabhaskararao; Burton, Amanda R.; Kanneganti, Thirumala-Devi (2020-12-11).
"RIPK1 Distinctly Regulates Yersinia-Induced Inflammatory Cell Death, PANoptosis" . ImmunoHorizons . 4 (12): 789–796.
doi :
10.4049/immunohorizons.2000097 .
ISSN
2573-7732 .
PMC
7906112 .
PMID
33310881 .
^
a
b
c Sundaram, Balamurugan; Pandian, Nagakannan; Mall, Raghvendra; Wang, Yaqiu; Sarkar, Roman; Kim, Hee Jin; Malireddi, R. K. Subbarao; Karki, Rajendra; Janke, Laura J.; Vogel, Peter; Kanneganti, Thirumala-Devi (2023-06-22).
"NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs" . Cell . 186 (13): 2783–2801.e20.
doi :
10.1016/j.cell.2023.05.005 .
ISSN
1097-4172 .
PMC
10330523 .
PMID
37267949 .
^
a
b Sundaram, Balamurugan; Pandian, Nagakannan; Kim, Hee Jin; Abdelaal, Hadia M.; Mall, Raghvendra; Indari, Omkar; Sarkar, Roman; Tweedell, Rebecca E.; Alonzo, Emily Q.; Klein, Jonathon; Pruett-Miller, Shondra M.; Vogel, Peter; Kanneganti, Thirumala-Devi (June 2024).
"NLRC5 senses NAD+ depletion, forming a PANoptosome and driving PANoptosis and inflammation" . Cell .
doi :
10.1016/j.cell.2024.05.034 .
ISSN
0092-8674 .
PMID
38878777 .
^
a
b
"St. Jude scientists solve decades long mystery of NLRC5 sensor function in cell death and disease" . www.stjude.org . Retrieved 2024-06-18 .
^ Man, Si Ming; Kanneganti, Thirumala-Devi (May 2015).
"Regulation of inflammasome activation" . Immunological Reviews . 265 (1): 6–21.
doi :
10.1111/imr.12296 .
ISSN
1600-065X .
PMC
4400844 .
PMID
25879280 .
^ Shi, Jianjin; Zhao, Yue; Wang, Kun; Shi, Xuyan; Wang, Yue; Huang, Huanwei; Zhuang, Yinghua; Cai, Tao; Wang, Fengchao; Shao, Feng (2015-10-29).
"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death" . Nature . 526 (7575): 660–665.
Bibcode :
2015Natur.526..660S .
doi :
10.1038/nature15514 .
ISSN
1476-4687 .
PMID
26375003 .
S2CID
4407455 .
^ He, Wan-ting; Wan, Haoqiang; Hu, Lichen; Chen, Pengda; Wang, Xin; Huang, Zhe; Yang, Zhang-Hua; Zhong, Chuan-Qi; Han, Jiahuai (December 2015).
"Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion" . Cell Research . 25 (12): 1285–1298.
doi :
10.1038/cr.2015.139 .
ISSN
1748-7838 .
PMC
4670995 .
PMID
26611636 .
^ Aglietti, Robin A.; Estevez, Alberto; Gupta, Aaron; Ramirez, Monica Gonzalez; Liu, Peter S.; Kayagaki, Nobuhiko; Ciferri, Claudio; Dixit, Vishva M.; Dueber, Erin C. (2016-07-12).
"GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes" . Proceedings of the National Academy of Sciences of the United States of America . 113 (28): 7858–7863.
Bibcode :
2016PNAS..113.7858A .
doi :
10.1073/pnas.1607769113 .
ISSN
1091-6490 .
PMC
4948338 .
PMID
27339137 .
^ Sborgi, Lorenzo; Rühl, Sebastian; Mulvihill, Estefania; Pipercevic, Joka; Heilig, Rosalie; Stahlberg, Henning; Farady, Christopher J.; Müller, Daniel J.; Broz, Petr; Hiller, Sebastian (2016-08-15).
"GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death" . The EMBO Journal . 35 (16): 1766–1778.
doi :
10.15252/embj.201694696 .
ISSN
1460-2075 .
PMC
5010048 .
PMID
27418190 .
^ Kayagaki, Nobuhiko; Warming, Søren; Lamkanfi, Mohamed; Vande Walle, Lieselotte; Louie, Salina; Dong, Jennifer; Newton, Kim; Qu, Yan; Liu, Jinfeng; Heldens, Sherry; Zhang, Juan; Lee, Wyne P.; Roose-Girma, Merone; Dixit, Vishva M. (2011-10-16).
"Non-canonical inflammasome activation targets caspase-11" . Nature . 479 (7371): 117–121.
Bibcode :
2011Natur.479..117K .
doi :
10.1038/nature10558 .
ISSN
1476-4687 .
PMID
22002608 .
S2CID
2131385 .
^ Martinon, Fabio; Burns, Kimberly; Tschopp, Jürg (July 2002).
"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta" . Molecular Cell . 10 (2): 417–426.
doi :
10.1016/s1097-2765(02)00599-3 .
ISSN
1097-2765 .
PMID
12191486 .
^ Zhao, Jie; Jitkaew, Siriporn; Cai, Zhenyu; Choksi, Swati; Li, Qiuning; Luo, Ji; Liu, Zheng-Gang (2012-04-03).
"Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis" . Proceedings of the National Academy of Sciences of the United States of America . 109 (14): 5322–5327.
Bibcode :
2012PNAS..109.5322Z .
doi :
10.1073/pnas.1200012109 .
ISSN
1091-6490 .
PMC
3325682 .
PMID
22421439 .
^ Sun, Liming; Wang, Huayi; Wang, Zhigao; He, Sudan; Chen, She; Liao, Daohong; Wang, Lai; Yan, Jiacong; Liu, Weilong; Lei, Xiaoguang; Wang, Xiaodong (2012-01-20).
"Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase" . Cell . 148 (1–2): 213–227.
doi :
10.1016/j.cell.2011.11.031 .
ISSN
1097-4172 .
PMID
22265413 .
^ Galluzzi, Lorenzo; Kepp, Oliver; Chan, Francis Ka-Ming; Kroemer, Guido (2017-01-24).
"Necroptosis: Mechanisms and Relevance to Disease" . Annual Review of Pathology . 12 : 103–130.
doi :
10.1146/annurev-pathol-052016-100247 .
ISSN
1553-4014 .
PMC
5786374 .
PMID
27959630 .
^ Dhuriya, Yogesh K.; Sharma, Divakar (2018-07-06).
"Necroptosis: a regulated inflammatory mode of cell death" . Journal of Neuroinflammation . 15 (1): 199.
doi :
10.1186/s12974-018-1235-0 .
ISSN
1742-2094 .
PMC
6035417 .
PMID
29980212 .
^ Lukens, John R.; Gurung, Prajwal; Vogel, Peter; Johnson, Gordon R.; Carter, Robert A.; McGoldrick, Daniel J.; Bandi, Srinivasa Rao; Calabrese, Christopher R.; Vande Walle, Lieselotte; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi (2014-12-11).
"Dietary modulation of the microbiome affects autoinflammatory disease" . Nature . 516 (7530): 246–249.
Bibcode :
2014Natur.516..246L .
doi :
10.1038/nature13788 .
ISSN
1476-4687 .
PMC
4268032 .
PMID
25274309 .
^ Gurung, Prajwal; Burton, Amanda; Kanneganti, Thirumala-Devi (2016-04-19).
"NLRP3 inflammasome plays a redundant role with caspase 8 to promote IL-1β-mediated osteomyelitis" . Proceedings of the National Academy of Sciences of the United States of America . 113 (16): 4452–4457.
doi :
10.1073/pnas.1601636113 .
ISSN
1091-6490 .
PMC
4843439 .
PMID
27071119 .
^ Kuriakose, Teneema; Man, Si Ming; Malireddi, R. K. Subbarao; Karki, Rajendra; Kesavardhana, Sannula; Place, David E.; Neale, Geoffrey; Vogel, Peter; Kanneganti, Thirumala-Devi (2016-08-05).
"ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways" . Science Immunology . 1 (2): aag2045.
doi :
10.1126/sciimmunol.aag2045 .
ISSN
2470-9468 .
PMC
5131924 .
PMID
27917412 .
^ Christgen, Shelbi; Zheng, Min; Kesavardhana, Sannula; Karki, Rajendra; Malireddi, R. K. Subbarao; Banoth, Balaji; Place, David E.; Briard, Benoit; Sharma, Bhesh Raj; Tuladhar, Shraddha; Samir, Parimal; Burton, Amanda; Kanneganti, Thirumala-Devi (2020).
"Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)" . Frontiers in Cellular and Infection Microbiology . 10 : 237.
doi :
10.3389/fcimb.2020.00237 .
ISSN
2235-2988 .
PMC
7274033 .
PMID
32547960 .
^ Malireddi, R. K. Subbarao; Kesavardhana, Sannula; Karki, Rajendra; Kancharana, Balabhaskararao; Burton, Amanda R.; Kanneganti, Thirumala-Devi (2020-12-11).
"RIPK1 Distinctly Regulates Yersinia-Induced Inflammatory Cell Death, PANoptosis" . ImmunoHorizons . 4 (12): 789–796.
doi :
10.4049/immunohorizons.2000097 .
ISSN
2573-7732 .
PMC
7906112 .
PMID
33310881 .
^ Chen, Wen; Gullett, Jessica M.; Tweedell, Rebecca E.; Kanneganti, Thirumala-Devi (November 2023).
"Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease" . European Journal of Immunology . 53 (11): e2250235.
doi :
10.1002/eji.202250235 .
ISSN
1521-4141 .
PMC 10423303.
PMID
36782083 .
^ Malireddi, R. K. Subbarao; Bynigeri, Ratnakar R.; Mall, Raghvendra; Connelly, Jon P.; Pruett-Miller, Shondra M.; Kanneganti, Thirumala-Devi (2023-10-20).
"Inflammatory cell death, PANoptosis, screen identifies host factors in coronavirus innate immune response as therapeutic targets" . Communications Biology . 6 (1): 1071.
doi :
10.1038/s42003-023-05414-9 .
ISSN
2399-3642 .
PMC
10589293 .
PMID
37864059 .
^ Jiang, Mingxia; Qi, Ling; Li, Lisha; Wu, Yiming; Song, Dongfeng; Li, Yanjing (2021-10-01).
"Caspase-8: A key protein of cross-talk signal way in "PANoptosis" in cancer" . International Journal of Cancer . 149 (7): 1408–1420.
doi :
10.1002/ijc.33698 .
ISSN
1097-0215 .
PMID
34028029 .
^ Someda, Masataka; Kuroki, Shunsuke; Miyachi, Hitoshi; Tachibana, Makoto; Yonehara, Shin (May 2020).
"Caspase-8, receptor-interacting protein kinase 1 (RIPK1), and RIPK3 regulate retinoic acid-induced cell differentiation and necroptosis" . Cell Death and Differentiation . 27 (5): 1539–1553.
doi :
10.1038/s41418-019-0434-2 .
ISSN
1476-5403 .
PMC
7206185 .
PMID
31659279 .
^ Rodriguez, Diego A.; Quarato, Giovanni; Liedmann, Swantje; Tummers, Bart; Zhang, Ting; Guy, Cliff; Crawford, Jeremy Chase; Palacios, Gustavo; Pelletier, Stephane; Kalkavan, Halime; Shaw, Jeremy J. P.; Fitzgerald, Patrick; Chen, Mark J.; Balachandran, Siddharth; Green, Douglas R. (2022-10-11).
"Caspase-8 and FADD prevent spontaneous ZBP1 expression and necroptosis" . Proceedings of the National Academy of Sciences of the United States of America . 119 (41): e2207240119.
doi :
10.1073/pnas.2207240119 .
ISSN
1091-6490 .
PMC
9565532 .
PMID
36191211 .
^ Cai, Hantao; Lv, Mingming; Wang, Tingting (December 2023).
"PANoptosis in cancer, the triangle of cell death" . Cancer Medicine . 12 (24): 22206–22223.
doi :
10.1002/cam4.6803 .
ISSN
2045-7634 .
PMC
10757109 .
PMID
38069556 .
^ Malireddi, R. K. Subbarao; Karki, Rajendra; Sundaram, Balamurugan; Kancharana, Balabhaskararao; Lee, SangJoon; Samir, Parimal; Kanneganti, Thirumala-Devi (2021-07-21).
"Inflammatory Cell Death, PANoptosis, Mediated by Cytokines in Diverse Cancer Lineages Inhibits Tumor Growth" . ImmunoHorizons . 5 (7): 568–580.
doi :
10.4049/immunohorizons.2100059 .
ISSN
2573-7732 .
PMC
8522052 .
PMID
34290111 .
^ Karki, Rajendra; Sharma, Bhesh Raj; Lee, Ein; Banoth, Balaji; Malireddi, R. K. Subbarao; Samir, Parimal; Tuladhar, Shraddha; Mummareddy, Harisankeerth; Burton, Amanda R.; Vogel, Peter; Kanneganti, Thirumala-Devi (2020-06-18).
"Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer" . JCI Insight . 5 (12): e136720, 136720.
doi :
10.1172/jci.insight.136720 .
ISSN
2379-3708 .
PMC
7406299 .
PMID
32554929 .
^ Sharma, Bhesh Raj; Kanneganti, Thirumala-Devi (February 2023).
"Inflammasome signaling in colorectal cancer" . Translational Research: The Journal of Laboratory and Clinical Medicine . 252 : 45–52.
doi :
10.1016/j.trsl.2022.09.002 .
ISSN
1878-1810 .
PMC
9839553 .
PMID
36150688 .
^ Mall, Raghvendra; Bynigeri, Ratnakar R.; Karki, Rajendra; Malireddi, R. K. Subbarao; Sharma, Bhesh Raj; Kanneganti, Thirumala-Devi (December 2022).
"Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology" . NAR Cancer . 4 (4): zcac033.
doi :
10.1093/narcan/zcac033 .
ISSN
2632-8674 .
PMC
9623737 .
PMID
36329783 .
^ Pan, Hongda; Pan, Jingxin; Li, Pei; Gao, Jianpeng (May 2022).
"Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer" . Clinical Immunology (Orlando, Fla.) . 238 : 109019.
doi :
10.1016/j.clim.2022.109019 .
ISSN
1521-7035 .
PMID
35470064 .
S2CID
248362726 .
^ He, Puxing; Ma, Yixuan; Wu, Yaolu; Zhou, Qing; Du, Huan (2023).
"Exploring PANoptosis in breast cancer based on scRNA-seq and bulk-seq" . Frontiers in Endocrinology . 14 : 1164930.
doi :
10.3389/fendo.2023.1164930 .
ISSN
1664-2392 .
PMC
10338225 .
PMID
37455906 .
^ Sun, Yanyan; Zhu, Changlian (February 2023).
"Potential role of PANoptosis in neuronal cell death: commentary on "PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons" " . Neural Regeneration Research . 18 (2): 339–340.
doi :
10.4103/1673-5374.346483 .
ISSN
1673-5374 .
PMC
9396522 .
PMID
35900425 .
^ Qi, Zehong; Zhu, Lili; Wang, Kangkai; Wang, Nian (2023-11-15).
"PANoptosis: Emerging mechanisms and disease implications" . Life Sciences . 333 : 122158.
doi :
10.1016/j.lfs.2023.122158 .
ISSN
1879-0631 .
PMID
37806654 .
S2CID
263775829 .
^ Zhu, Peng; Ke, Zhuo-Ran; Chen, Jing-Xian; Li, Shi-Jin; Ma, Tian-Liang; Fan, Xiao-Lei (2023).
"Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment" . Frontiers in Immunology . 14 : 1120034.
doi :
10.3389/fimmu.2023.1120034 .
ISSN
1664-3224 .
PMC
9948402 .
PMID
36845112 .
^ Karki, Rajendra; Sharma, Bhesh Raj; Tuladhar, Shraddha; Williams, Evan Peter; Zalduondo, Lillian; Samir, Parimal; Zheng, Min; Sundaram, Balamurugan; Banoth, Balaji; Malireddi, R. K. Subbarao; Schreiner, Patrick; Neale, Geoffrey; Vogel, Peter; Webby, Richard; Jonsson, Colleen Beth (2021-01-07).
"Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes" . Cell . 184 (1): 149–168.e17.
doi :
10.1016/j.cell.2020.11.025 .
ISSN
1097-4172 .
PMC
7674074 .
PMID
33278357 .
^ Subbarao Malireddi, R.K.; Karki, Rajendra; Sundaram, Balamurugan; Kancharana, Balabhaskararao; Lee, SangJoon; Samir, Parimal; Kanneganti, Thirumala-Devi (2021-07-21).
"Inflammatory cell death, PANoptosis, mediated by cytokines in diverse cancer lineages inhibits tumor growth" . ImmunoHorizons . 5 (7): 568–580.
doi :
10.4049/immunohorizons.2100059 .
ISSN
2573-7732 .
PMC
8522052 .
PMID
34290111 .
^ Karki, Rajendra; Sundaram, Balamurugan; Sharma, Bhesh Raj; Lee, SangJoon; Malireddi, R.K. Subbarao; Nguyen, Lam Nhat; Christgen, Shelbi; Zheng, Min; Wang, Yaqiu; Samir, Parimal; Neale, Geoffrey; Vogel, Peter; Kanneganti, Thirumala-Devi (2021-10-19).
"ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis" . Cell Reports . 37 (3): 109858.
doi :
10.1016/j.celrep.2021.109858 .
ISSN
2211-1247 .
PMC
8853634 .
PMID
34686350 .
^ Karki, Rajendra; Kanneganti, Thirumala-Devi (August 2021).
"The 'Cytokine Storm': molecular mechanisms and therapeutic prospects" . Trends in Immunology . 42 (8): 681–705.
doi :
10.1016/j.it.2021.06.001 .
ISSN
1471-4906 .
PMC
9310545 .
PMID
34217595 .
^ Karki, Rajendra; Sharma, Bhesh Raj; Tuladhar, Shraddha; Williams, Evan Peter; Zalduondo, Lillian; Samir, Parimal; Zheng, Min; Sundaram, Balamurugan; Banoth, Balaji; Malireddi, R.K. Subbarao; Schreiner, Patrick; Neale, Geoffrey; Vogel, Peter; Webby, Richard; Jonsson, Colleen Beth (2021-01-07).
"Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes" . Cell . 184 (1): 149–168.e17.
doi :
10.1016/j.cell.2020.11.025 .
ISSN
0092-8674 .
PMC
7674074 .
PMID
33278357 .
^ Oh, SuHyeon; Lee, SangJoon (2023).
"Recent advances in ZBP1-derived PANoptosis against viral infections" . Frontiers in Immunology . 14 : 1148727.
doi :
10.3389/fimmu.2023.1148727 .
ISSN
1664-3224 .
PMC
10228733 .
PMID
37261341 .
^ Schifanella, Luca; Anderson, Jodi; Wieking, Garritt; Southern, Peter J.; Antinori, Spinello; Galli, Massimo; Corbellino, Mario; Lai, Alessia; Klatt, Nichole; Schacker, Timothy W.; Haase, Ashley T. (2023-05-29).
"The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2 and Necroptosis, Pyroptosis, and PANoptosis" . The Journal of Infectious Diseases . 227 (11): 1245–1254.
doi :
10.1093/infdis/jiad056 .
ISSN
1537-6613 .
PMC
10226656 .
PMID
36869698 .
^ Han, Joo-Hui; Karki, Rajendra; Malireddi, R. K. Subbarao; Mall, Raghvendra; Sarkar, Roman; Sharma, Bhesh Raj; Klein, Jonathon; Berns, Harmut; Pisharath, Harshan; Pruett-Miller, Shondra M.; Bae, Sung-Jin; Kanneganti, Thirumala-Devi (2024-02-26).
"NINJ1 mediates inflammatory cell death, PANoptosis, and lethality during infection conditions and heat stress" . Nature Communications . 15 (1): 1739.
doi :
10.1038/s41467-024-45466-x .
ISSN
2041-1723 .
PMC
10897308 .
PMID
38409108 .